Bernard Pirotte
About
In The Last Decade
Bernard Pirotte
221 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 132
- Molecular Biology 1.8k
- Organic Chemistry 1.7k
- Pharmacology 804
- Cellular and Molecular Neuroscience 610
- Pathology and Forensic Medicine 323
Countries citing papers authored by Bernard Pirotte
This map shows the geographic impact of Bernard Pirotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Pirotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Pirotte more than expected).
Fields of papers citing papers by Bernard Pirotte
This network shows the impact of papers produced by Bernard Pirotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Pirotte. The network helps show where Bernard Pirotte may publish in the future.
Co-authorship network of co-authors of Bernard Pirotte
This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Pirotte. A scholar is included among the top collaborators of Bernard Pirotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Pirotte. Bernard Pirotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | Synthesis and vasodilator activity of 3,4-dihydropyrimidin-2(1H)-ones bearing urea, thiourea and sulfonylurea moieties | 2 |
| 5 | 6 | |
| 6 | From Metabolomics to Identification of a new therapeutic approach for Age-Related Macular Degeneration (AMD) | 1 |
| 7 | 115 | |
| 8 | 17 | |
| 9 | 23 | |
| 10 | 47 | |
| 11 | 24 | |
| 12 | 68 | |
| 13 | Synthesis and pharmacological evaluation of ATP-sensitive potassium channel openers related to cromakalim: introduction of arylsulfonylurea or benzothiadiazinedioxide moieties | 1 |
| 14 | The chemistry of 3-phthalimidomethyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides and their use in the synthesis of potential cholecystokinin/gastrin receptor ligands | 0 |
| 15 | 81 | |
| 16 | Recent advances in the chemistry of potassium channel openers | 37 |
| 17 | Les sulfamidés diurétiques : des origines aux perspectives d'avenir | 1 |
| 18 | 5-Phenylacetylaminothiazolium salts and their reactions with nucleophiles | 2 |
| 19 | Synthesis and biological evaluation of 5-aminothiazole and 4-amino- 1,2,4-triazole derivatives, potential inhibitors of bacterial serine enzymes | 1 |
| 20 | Etude de la cinétique de libération "in vitro" de la nitroglycérine à partir de quelques systèmes d'administration percutanée | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.